SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Community sentiment remains heavily polarized as traders weigh the potential market impact of proposed economic sanctions against Iran and ongoing trade friction with Canada. Discussion is dominated by heated political debates and speculation regarding pending mergers and corporate catalysts that could influence the stock's future direction.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant volatility as retail investors weigh delayed launch updates and broader sector pressure against the company's strong commercial partnerships, including a potential high-stakes interest in 800 MHz spectrum. While the community remains divided over management's communication and the pace of satellite deployment, many shareholders are viewing the current price consolidation as a long-term buying opportunity.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the potential for a long-term recovery, fueled by persistent community discussions regarding its utility in payment infrastructure and the ongoing impact of regulatory milestones like the CLARITY Act. While some community members remain optimistic about stacking during current price levels, others express frustration over historical performance and leadership changes, highlighting a deep divide in sentiment.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending due to the company establishing a new $1.59 billion USD cash pool, sparking significant community debate over its ongoing share dilution versus its strategy to increase liquidity. Investors are actively discussing the stock's role as a proxy for Bitcoin, with sentiment split between bullish expectations for a squeeze and skepticism regarding the sustainability of the company's financing model.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trading higher as the broader crypto sector rallies on expectations surrounding a White House meeting with industry executives to discuss the Clarity Act and Treasury liquidity measures. Community sentiment is sharply divided between optimistic investors targeting further upside in the crypto bull run and skeptical traders who view the recent move as a temporary rally in a struggling stock.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors weigh its upcoming earnings against broader semiconductor sector volatility, with community sentiment divided between expectations of a blowout performance and skepticism fueled by circular financing concerns. Traders are actively debating whether current price action represents a strategic shakeout before a post-earnings rally or a deeper correction linked to macro-economic uncertainty.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

UAMY is trending as investors react to a significant revenue miss and a lowered annual guidance, driven by a sharp decline in antimony prices. Community discussion remains polarized between frustrated investors concerned about management's execution and those viewing the dip as a long-term accumulation opportunity for a critical domestic mineral producer.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is attracting significant institutional attention as investors monitor its expanding oncology pipeline and ongoing M&A activity following a series of strategic acquisitions, including Assembly Biosciences and Arcellx. Community discourse remains heavily focused on the company's HIV franchise strength and potential long-term value as the stock maintains a technical base near key support levels.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is facing intense market pressure following an FDA clinical hold on its experimental Hunter syndrome gene therapy, RGX-121, after asymptomatic spinal abnormalities were discovered in trial participants. While the company stated that investigators and radiologists consider these findings benign and reported no neurocognitive decline, investors are expressing frustration over the lack of a near-term path forward and are debating whether the stock's current price is an extreme overreaction to the regulatory setback.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is seeing increased investor scrutiny and community activity as shareholders weigh heavy insider accumulation against recent technical volatility and earnings guidance adjustments. The stock is a frequent subject of bottom-fishing debates, with the community closely tracking institutional sentiment and potential turnaround catalysts in its medical device pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EOG Stock Is Up 14.8% in 3 Months: Can Its Strong Rally Keep Going?

EOG's strong Q2 2026, production growth and robust free cash flow support its rally, while valuation and lower 2027 earnings raise the bar.

Cost Savings and Production Growth Strengthen ExxonMobil's Outlook

XOM's advantaged Guyana and Permian assets, cost savings and production growth support its earnings and cash-flow outlook.

Here's Why EOG Resources (EOG) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

MGY's $4.06B WildFire Deal Could Reshape Its Growth and Risk Profile

Magnolia Oil & Gas' $4.06B WildFire deal can sharply expand Giddings' scale, oil exposure and inventory, while adding leverage and dilution risks.

SM Energy Slides 11.2% in One Week: Could the Dip Be an Opportunity?

SM's Q2 beat, higher production outlook and faster debt reduction temper an 11.2% weekly slide, but leverage and inventory risks keep the setup mixed.

EOG Q2 Earnings Call Highlights UAE Progress & Cost Discipline

EOG Resources' record cash generation, promising UAE wells and tight cost controls frame a disciplined plan balancing selective growth, flexibility and cash returns.

EOG Q2 Earnings Beat Estimates on Higher Volumes & Prices

EOG's Q2 earnings beat estimates as higher oil prices and a 24.4% production gain fueled a 57.4% revenue surge and strong free cash flow.

EOG Resources (EOG) Beats Q2 Earnings and Revenue Estimates

EOG Resources (EOG) delivered earnings and revenue surprises of +1.20% and +9.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

EOG Resources Profit Climbs In Q2

(RTTNews) - EOG Resources (EOG) announced earnings for its second quarter that Increases, from the same period last year...

Exploring Analyst Estimates for EOG Resources (EOG) Q2 Earnings, Beyond Revenue and EPS

Get a deeper insight into the potential performance of EOG Resources (EOG) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX.

EOG Resources, Inc.

EOG Resources To Acquire Encino Acquisition Partners For $5.6B

Equity

Bullish Sentiment

Beat EPS and revenue 

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Nvidia ($NVDA) reports Q2 earnings Wednesday with Wall Street expecting roughly $91.7 billion in revenue — about 80% year-over-year growth — and EPS near $2.08. What do you expect in terms of revenue and EPS? Vote and explain your reasoning in the comments.

What do you expect from Nvidia ($NVDA) earnings on Wednesday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$4.04	--	--	N/A
Q2 '26	$4.97	$5.07	1.97%	BEAT
Q1 '26	$3.23	$3.41	5.49%	BEAT
Q4 '25	$2.19	$2.27	3.78%	BEAT
Q3 '25	$2.46	$2.71	10.21%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings